Zeitschrift für Phytotherapie 2010; 31(2): 110-118
DOI: 10.1055/s-0030-1247648
Porträt einer Arzneipflanze

© Hippokrates Verlag in MVS Medizinverlage Stuttgart GmbH & Co. KG

Garcinia mangostana L. – Ein phytochemisches und pharmakologisches Porträt[*]

Dmitriy Obolskiy 1 , Ivo Pischel 1, 2 , Nisarat Siriwatanametanon 1 , Michael Heinrich 1
  • 1Center for Pharmacognosy and Phytotherapy, The School of Pharmacy (University of London)
  • , 29-39 Brunswick Sq.
  • , London WC1N 1AX
  • , UK
  • 2Phytolab GmbH & Co. KG
  • , Dutendorfer Str. 5-7
  • , 91487 Vestenbergsgreuth
Further Information

Publication History

Publication Date:
10 May 2010 (online)

Zusammenfassung

Mangostane (auch Mangostan, Mangostin; Carcinia mangostana L, Clusiaceae) hat eine lange Geschichte als Heilpflanze, v.a. in Südostasien. Dieser Artikel gibt einen Überblick über die Pharmakologie der Pflanze. Traditionell ist Mangostane für ihre entzündungshemmenden Eigenschaften bekannt und wird zur Behandlung von Hautinfektionen und Wunden verwendet. Andere Anwendungsbereiche umfassen die Therapie unterschiedlicher Störungen wie Dysenterie, Erkrankungen der Harnwege, Zystitis und Gonorrhö. Dieser Review-Artikel beleuchtet die Entwicklung der pflanzlichen Droge zu einem weitverbreiteten Nutraceutical. Produkte aus G. mangostana werden heute weltweit vermarktet. Das hat zu einer vermehrten Erforschung ihrer phytochemischen Bestandteile und deren biologischer Wirkungen geführt. Ausführlich vorgestellt werden die biologischen Aktivitäten einzelner Xan-thone sowie Extrakte von G. mangostana. Außerdem wird das Potenzial der Pflanze im Hinblick auf die Entwicklung neuer Wirkstoffe (oder Leitsubstanzen) beleuchtet. Produkte aus den Früchten werden inzwischen verbreitet als flüssige pflanzliche Nahrungsergänzungsmittel verkauft, doch Nachweise über die gesundheitlichen Wirkungen dieser Produkte stehen noch aus. Es fehlen klinische Daten und noch ist unklar, ob die Erkenntnisse über die pharmakologischen Wirkungen auch von klinischer Relevanz sind.

Summary

Garcinia mangostana L: a phytochemical and pharmacological review

Garcinia mangostana L. (mangosteen, Clusiaceae) has a long history of use as a medi-cal plant, mostly in Southeast Asia. Here we review the phytochemistry and pharma-cology of mangosteen. Traditionally mangosteen is famous for its antiinflammatory properties and is used in the treatment of skin infections and wounds. Other appli-cations include the therapy of various conditions such as dysentery, different urinary disorders, cystitis and gonorrhoea. This review highlights the development of this botanical drug into a widely used nutraceutical. Products derived from G. mangostana are now increasingly employed all over the world. This has given rise to a concomitant increase in research on the phytochemical constituents and biological activity of mangosteen. Central to the biological activity of the species are xanthones. A comprehensive assessment of the biological activities of individual xanthones as well as extracts of G. mangostana is included. In addition, its potential in terms of developing novel drug leads is assessed. Products containing its fruits are now sold widely as ‘liquid botanical Supplements’, but evidence for the health benefits of these products is still lacking. As shown here, a serious weakness in our knowledge is the lack of clinical data and it is not yet clear to what extent the findings about pharmacological activities are of potential clinical relevance.

10 Aktualisierte Version eines Artikels von Obolskiy et al. in Phytotherapy Research 2009; 27: 1047-1065, mit vollständiger Literaturliste.

10 Aktualisierte Version eines Artikels von Obolskiy et al. in Phytotherapy Research 2009; 27: 1047-1065, mit vollständiger Literaturliste.

Literatur

  • r1 Bumrungpert A., Kalpravidh RW., Chitch-mroonchokchai C. , et al. Xanthones from mangosteen prevent lipopolysaccharide-mediated inflammation and insulin resistance in primary cultures of human adipocytes.  J Nutr. 2009;  139 1185-1191
  • r2 Chairungsrilerd N., Furukawa K., Ohta T. , et al. Histaminergic and serotonergic receptor blocking substances from the medicinal plant Garcinia mangostana. .  Planta Med. 1996;  62 471-472
  • r3 Chairungsrilerd N., Furukawa Kl., Ohta T. , et al. Gamma-mangostin, a novel type of 5-hy-droxytryptamine 2A receptor antagonist.  Naunyn Schmiedebergs Arch Pharmacol. 1998;  357 25-31
  • r4 Chanarat P., Chanarat N., Fujihara M., Nagumo T.. Immunopharmacological activity of Polysaccharide from the pericarb of mangosteen: phagocytic intracellular killing activi-ties.  J Med Assoc Thai. 1997;  80 (S 1) S149-S154
  • r5 Chanprechakul A.. Antimutagenicity activity of Thai herbal beverages. In: Research Reports. Thai Traditional Medicine and Future Prospective. Institute of Thai Traditional Medicine, Ministry of Public Health. Nontaburi Province. Thailand; 2000: 109
  • r6 Chen LG., Yang LL., Wang CC.. Anti-inflamma-tory activity of mangostins from Garcinia mangostana. .  Food Chem Toxicol. 2008;  46 688-693
  • r7 Chen SX., Wan M., Loh BN.. Active con-stituents against HIV-1 protease from Garcinia mangostana. .  Planta Med. 1996;  62 381-382
  • r8 Chin YW., Jung HA., Chai H. , et al. Xanthones with quinone reductase-inducing activity from the fruits of Garcinia mangostana (Mangosteen).  Phytochemistry. 2008;  69 754-758
  • r9 Chomnawang MT., Surassmo S., Nukoolkarn VS., Gritsanapan W.. Effect of Garcinia mangostana on inflammation caused by Propionibacterium acnes. .  Fitoterapia. 2007;  78 401-408
  • r10 Ee GC., Daud S., Taufiq-Yap YH. , et al. Xanthones from Garcinia mangostana (Gutti-ferae).  Nat Prod Res. 2006;  20 1067-1073
  • r11 Ee CLG., Shaari D., Sheikh Al., Mawardi R.. Garcinia mangostana: a source of potential anti-cancer lead Compounds against CEM-SS cell line.  J Asian Nat Prod Res. 2008;  10 475-479
  • r12 Farnsworth RN., Bunyapraphatsara N.. Garcinia mangostana Linn. In: Farnsworth NR, Bunyapraphatsara N, eds. Thai Medicinal Plants. Bangkok; Prachachon 1992: 160-162
  • r13 Gopalakrishnan G., Banumathi B., Suresh G.. Evaluation of the antifungal activity of natural xanthones from Garcinia mangostana and their synthetic derivatives.  J Nat Prod. 1997;  60 519-524
  • r14 Gritsanapan W., Chulasiri M.. A preliminary study of antidiarrheal plants and antibacte-rial activity.  Mahidol Univ J Pharm Sei. 1983;  10 119-122
  • r15 Guzman-Beltran S., Orozco-Ibarra M, Gonzalez-Cuahutencos O. , et al. Neuroprotective effect and reactive oxygen species seaveng-ing capacity of mangosteen pericarp extract in cultured neurons.  Curr Top Nutraceut R. 2008;  6 149-157
  • r16 Harrison NLJ.. Xanthones from the heart-wood of Garcinia mangostana. .  Phytochemistry. 2002;  60 541-548
  • r17 Heinrich M., Leonti M., Nebel S. , et al. "Local Food - Nutraceuticals": Bridging thegap between local knowledge and global needs.  Forum of Nutrition. 2006;  59 1-17
  • r18 Heinrich M., Prieto JM.. 2008. Dietand healthy ageing 2100: Will we globalise local knowledge Systems?.  Ageing Res Rev. 2008;  7 249-274
  • r19 Ho CK., Huang YL., Chen CC.. Garcinone E, a xanthone derivative, has potent cytotoxic effect against hepatocellular Carcinoma cell lines.  Planta Med. 2002;  68 975-979
  • r20 Hung SH., Shen KH., Wu C.. , et al. alpha-Man-gostin suppresses PC-3 human prostate Carcinoma cell metastasis by inhibiting matrix metalloproteinase-2/9 and urokinase-plas-minogen expression through the JNK signal-ing pathway.  J Agric Food Chem. 2009;  57 1291-1298
  • r21 http://www.xango.co.jp/pressrelease/archive/060324_en.html (March 3, 2006). ‘State of the category 2006’
  • r22 Iinuma M., Tosa H., Tanaka T. , et al. Antibacter-ial activity of xanthones from guttiferaeous plants against methicillin-resistant Staphylo-coccus aureus. .  Pharm Pharmacol. 1996;  48 861-865
  • r23 Jung HA., Su BN., Keller W.. , et al. Antioxidant xanthones from the pericarp of Garcinia mangostana (Mangosteen).  J Agric Food Chem. 2006;  54 2077-2082
  • r24 Lim AH.. The embriology of Garcinia mangostana L. (Clusiaceae).  Gard Bull Sing. 1984;  37 93-103
  • r25 Limei Y., Mouming Z.. Immunomodulatory and anticancer activities of phenolics from Garcinia mangostana fruit pericarp.  Food Chem. 2009;  116 969-973
  • r26 Mahabusarakam W., Proudfoot J., Taylor W., Croft K.. Inhibition of lipoprotein Oxidation by prenylated xanthones derived from man-gostin.  Free Radic Res. 2000;  33 643-659
  • r27 Marquez-Valadez B, Lugo-Huitron R, Valdivia-Cedra V. , et al. The natural xanthone alpha-mangostin reduces oxidative damage in rat brain tissue.  Nutr Neurosci. 2009;  12 35-42
  • r28 Matsumoto K., Akao Y., Kobayashi E. , et al. Induction of apoptosis by xanthones from mangosteen in human leukemia cell lines.  J Nat Prod. 2003;  66 1124-1127
  • r29 Matsumoto K., Akao Y., Yi H. , et al. Preferential target is mitochondria in alpha-mangostininduced apoptosis in human leukemia HL60 cells.  Bioorg Med Chem. 2004;  12 5799-5806
  • r30 Matsumoto K., Akao Y., Ohguchi K. , et al. Xanthones induce cell-cycle arrest and apoptosis in human colon Cancer DLD-1 cells.  Bioorg Med Chem. 2005;  13 6064-6069
  • r31 Moongkarndi P., Kosem N., Kaslungka S. , et al. Antiproliferation, antioxidation and induc-tion of apoptosis by Garcinia mangostana (mangosteen) on SKBR3 human breast Cancer cell line.  J Ethnopharmacol. 2004;  90 161-166
  • r32 Moongkarndi P., Kosem N., Luanratana O. , et al. Antiproliferative activity of Thai medicinal plant extracts on human breast adenocarci-noma cell line.  Fitoterapia. 2004;  75 375-377
  • r33 Nabandith V., Suzui M., Morioka T. , et al. In-hibitory effects of crude alpha-mangostin, a xanthone derivative, on two different categories of colon preneoplastic lesions induced by 1,2-dimethylhydrazine in the rat.  Asian Pac J Cancer Prev. 2004;  5 433-438
  • r34 Nakatani K., Atsumi M., Arakawa T. , et al. Inhibitions of histamine release and Prostaglandin E2 synthesis by mangosteen, a Thai medicinal plant.  Biol Pharm Bull. 2002;  25 1137-1141
  • r35 Nakatani K., Nakahata N., Arakawa T. , et al. Inhibition of cyclooxygenase and Prostaglandin E2 synthesis by gamma-man-gostin, a xanthone derivative in mangosteen, in C6 ratglioma cells.  Biochem Pharmacol. 2002;  63 73-79
  • r36 Nakatani K., Yamakuni T., Kondo N. , et al. Gam-ma-Mangostin inhibits inhibitor-kappaB kinase activity and decreases lipopolysaccha-ride-induced cyclooxygenase-2 gene expres-sion in C6 ratglioma cells.  Mol Pharmacol. 2004;  66 667-674
  • r37 NBJ's Supplement Business Report. Nutrition Business Journal: New Hope Natural Media. Boulder, CO; Penton Media Inc. 2007
  • r38 Obolskiy D., Pischel I., Siriwatanametanon N., Heinrich M.. Garcinia mangostana L. (mangosteen): A phytochemical and pharmacological review.  Phytother Res. 2009;  27 1047-1065
  • r39 Peres V., Nagern TJ., Oliveira FF.. Tetraoxy-genated naturally occurring xanthones.  Phytochemistry. 2000;  55 683-710
  • r40 Pongphasuk N., Khunkitti W., Chitcharoenthum M.. Anti-inflammatory and analgesic activities of the extract from Garcinia mangostana Linn.  Acta Hort (ISHS). 2005;  680 125-130
  • r41 Puripattanavong JKW., Khajorndetkun W., Chansathirapanich W.. Improved isolation of a-mangostin from the fruit hull of Garcinia mangostana and its antioxidant and antifun-gal activity.  Planta Med. 2006;  72 1078
  • r42 Rasameemasmaung S., Sirikulsathen A., Amornchat C. , et al. Topical application of Garcinia mangostana L. pericarp gel as an adjunct to periodontal treatment.  Complement Ther Med. 2008;  16 262-267
  • r43 Rapport L., Lockwood GB.. Nutraceuticals. London; Pharmaceutical Press 2002
  • r44 Riscoe M., Kelly JX., Winter R.. Xanthones as antimalarial agents: discovery, mode of action, and optimization.  Curr Med Chem. 2005;  12 2539-2549
  • r45 Sakagami Y., Iinuma M., Piyasena KG., Dharmaratne HR.. Antibacterial activity of alpha-mangostin against vancomycin resistant Enterococci (VRE) and synergism with anti-biotics.  Phytomedicine. 2005;  12 203-208
  • r46 Sato A., Fujiwara H., Oku H. , et al. Alpha-man-gostin induces Ca2+-ATPase-dependent apoptosis via mitochondrial pathway in PCI 2 cells.  J Pharmacol Sei. 2004;  95 33-40
  • r47 Shankaranarayan D., Gopalakrishnan C., Kameswaran L.. Pharmacological profile of mangostin and its derivatives.  Arch Int Pharmacodyn Ther. 1979;  239 257-269
  • r48 Sornprasit A.. Preliminary toxicological study of mangostin.  Songklanakarin J Sei Technol. 1987;  9 51-57
  • r49 Sukatta U., Rugthaworn P., Pitpiangchan P., Dilokkunanant U.. Development of anti-aene gel with mangosteen crude extract. Proceedings of the 46th Kasetsart University Annual Conference Kasetasart Thailand; 29 Jan - 1 Feb 2008: 489-496
  • r50 Suksamrarn S., Suwannapoch N., Phakhodee W. , et al. Antimycobacterial activity of preny-lated xanthones from the fruits of Garünia mangostana. .  Chem Pharm Bull (Tokyo). 2003;  51 857-859
  • r51 Suksamrarn S., Komutiban O., Ratananukul P.. Cytotoxic prenylated xanthones from the young fruit of Garcinia mangostana.  Chem Pharm Bull (Tokyo). 2006;  54 301-305
  • r52 Sutabhaha B., Darntrakoon U., Furuya T., Nagumo T.. The inhibitory activities of man-gosteen's pericarb extract on methicillin-resistant Staphylococcus aureus. .  Bull Chiang Mai Assoc Med Sei. 1997;  30 40-46
  • r53 Tewtrakul S., Wattanapiromsakul C., Mahabusarakam W.. Effects of Compounds from Garcinia mangostana on inflammatory mediators in RAW264.7 macrophage cells.  J Ethnopharmacol. 2009;  121 379-382
  • r54 Toromanyan E., Aslanyan G., Amroyan E. , et al. Efficacy of Slim339 in reducing body weight of overweight and obese human subjects.  Phytother Res. 2007;  21 1177-1181
  • r55 Vlietinck AJ., Bruyne T., Apers S., Pieters LA.. Plant-derived leading compounds for chemotherapy of human immunodeficiency virus (HIV) infection.  Planta Med. 1998;  64 97-109
  • r56 Voravuthikunchai SP., Kitpipit L.. Activity of medicinal plant extracts against hospital isolates of methicillin-resistant Staphylococcus aureus.  Clin Microbiol Infect. 2005;  11 510-512
  • r57 Williams P., Ongsakul M., Proudfoot J. , et al. Mangostin inhibits the oxidative modification of human low density lipoprotein.  Free Radic Res. 1995;  23 175-184
  • r58 Wong LP., Klemmer PJ.. Severe lactic acidosis associated with Juice of the mangosteen fruit Garcinia mangostana. .  Am J Kidney Dis. 2008;  51 829-833
  • r59 Yu L., Zhao M., Yang B. , et al. Phenolics from hüll of Garcinia mangostana fruit and their antioxidant activities.  Food Chem. 2007;  104 176-181
  • r60 Zarena AS., Sankar KU.. A study of antioxidant properties from Garcinia mangostana L. pericarp extract.  Acta Sei Pol-Technologia Alimentaria. 2009;  8 23-34

Prof. Dr. Michael Heinrich

Center for Pharmacognosy and Phytotherapy, The School of Pharmacy (University of London)

29-39 Brunswick Sq.

London WC1 N 1AX, UK

Email: michael.heinrich@pharmacy.ac.uk

Online

http://dx.doi.org/10.1055/S-0030-1247648

    >